NET IMPACT ANALYSIS OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF ADULTS WITH MULTIPLE MYELOMA FOR QUEBEC

被引：0
|
作者：
Pettigrew, M. [1 ]
Garces, K. [2 ]
机构：
[1] Symbiose Partenariat Strateg Inc, Montreal, PQ, Canada
[2] Takeda Canada Inc, Oakville, ON, Canada
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.170
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN88
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [1] Combination of ixazomib, pomalidomide and dexamethasone in the treatment of multiple myeloma in relapse and refractory to lenalidomide
    Stocker, Nicolas
    [J]. HEMATOLOGIE, 2018, 24 (04): : 261 - 262
  • [2] BUDGET IMPACT OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN BRAZIL
    Sakagute, M.
    Tanaka, P. Y.
    Duva, A.
    Rigolon, J.
    [J]. VALUE IN HEALTH, 2019, 22 : S459 - S459
  • [3] BUDGET IMPACT OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA IN RUSSIA
    Pyadushkina, E.
    Derkach, E., V
    Boyarskaya, T.
    [J]. VALUE IN HEALTH, 2018, 21 : S26 - S26
  • [4] Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
    Moreau, P.
    Masszi, T.
    Grzasko, N.
    Bahlis, N. J.
    Hansson, M.
    Pour, L.
    Sandhu, I.
    Ganly, P.
    Baker, B. W.
    Jackson, S. R.
    Stoppa, A. -M.
    Simpson, D. R.
    Gimsing, P.
    Palumbo, A.
    Garderet, L.
    Cavo, M.
    Kumar, S.
    Touzeau, C.
    Buadi, F. K.
    Laubach, J. P.
    Berg, D. T.
    Lin, J.
    Di Bacco, A.
    Hui, A. -M.
    van de Velde, H.
    Richardson, P. G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (17): : 1621 - 1634
  • [5] Ixazomib, Lenalidomide and Dexamethasone: a new combination in cytogenetic high risk multiple myeloma
    Chiche, Edmond
    Leleu, Xavier
    Richez, Valentine
    [J]. HEMATOLOGIE, 2018, 24 (01): : 18 - 19
  • [6] Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis
    Takakuwa, Teruhito
    Yamamura, Ryosuke
    Ohta, Kensuke
    Kaneko, Hitomi
    Imada, Kazunori
    Nakaya, Aya
    Fuchida, Shin-ichi
    Shibayama, Hirohiko
    Matsuda, Mitsuhiro
    Shimazu, Yutaka
    Adachi, Yoko
    Kosugi, Satoru
    Uchiyama, Hitoji
    Tanaka, Hirokazu
    Hanamoto, Hitoshi
    Shimura, Yuji
    Kanda, Junya
    Onda, Yoshiyuki
    Uoshima, Nobuhiko
    Yagi, Hideo
    Yoshihara, Satoshi
    Hino, Masayuki
    Shimazaki, Chihiro
    Takaori-Kondo, Akifumi
    Kuroda, Junya
    Matsumura, Itaru
    Kanakura, Yuzuru
    Nomura, Shosaku
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (04) : 555 - 562
  • [7] A comparison of the efficacy and safety of ixazomib and lenalidomide combined with dexamethasone in the treatment of multiple myeloma
    Zheng, Zhipan
    Lin, Kai
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (05): : 5248 - 5255
  • [8] Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
    Kumar, Shaji K.
    Kapoor, Prashant
    Laplant, Betsy
    Phuong-Dung, Liang
    Muchtar, Eli
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Malave, Gabriella C.
    Vossen, Alanna M.
    Dingli, David
    Go, Ronald S.
    Warsame, Rahma M.
    Kourelis, Taxiarchis
    Hwa, Yi L.
    Fonder, Amie
    Hobbs, Miriam A.
    Lust, John A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Leung, Nelson
    Rajkumar, S. Vincent
    Gertz, Morie A.
    [J]. BLOOD, 2020, 136
  • [9] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
    Palumbo, Antonio
    Dimopoulos, Meletios
    San Miguel, Jesus
    Harousseau, Jean-Luc
    Attal, Michel
    Hussein, Mohamad
    Knop, Stefan
    Ludwig, Heinz
    von Lilienfeld-Toal, Marie
    Sonneveld, Pieter
    [J]. BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
  • [10] A Phase II Trial of the Combination of Ixazomib, Lenalidomide, and Dexamethasone in High-Risk Smoldering Multiple Myeloma
    Nadeem, Omar
    Reed, Robert A.
    Prescott, Julia
    Tague, Kelsey
    Romines, Veronica
    Metivier, Amada
    Savell, Alexandra
    Leblebjian, Houry
    Distaso, Alexandra
    Mo, Clifton C.
    Laubach, Jacob P.
    Sperling, Adam S.
    Richardson, Paul G.
    Ghobrial, Irene M.
    [J]. BLOOD, 2021, 138
12345